Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Juvéderm is a collection of injectable hyaluronic acid dermal fillers manufactured by Allergan Aesthetics. These products are formulated with a modified form of hyaluronic acid (HA), a naturally occurring sugar found in the body. Hyaluronic acid works by holding water at the injection site and acting as a cushioning agent, adding temporary volume and creating a smoother appearance to the skin. Most Juvéderm products also contain lidocaine, a local anesthetic that makes the injection process more comfortable. Each product in the Juvéderm collection is specifically designed for different facial areas and concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Juvéderm.